Robert W Dubois

Summary

Affiliation: Cerner Corporation
Country: USA

Publications

  1. ncbi request reprint Identification, diagnosis, and management of anemia in adult ambulatory patients treated by primary care physicians: evidence-based and consensus recommendations
    Robert W Dubois
    Cerner Health Insights, Beverly Hills, CA 90212, USA
    Curr Med Res Opin 22:385-95. 2006
  2. ncbi request reprint Geographic variation in the use of medications: is uniformity good news or bad?
    Robert W Dubois
    Zynx Health, Beverly Hills, California, USA
    Health Aff (Millwood) 21:240-50. 2002
  3. ncbi request reprint Guidelines for the appropriate use of non-steroidal anti-inflammatory drugs, cyclo-oxygenase-2-specific inhibitors and proton pump inhibitors in patients requiring chronic anti-inflammatory therapy
    R W Dubois
    Zynx Health Inc, Beverly Hills, CA 90212, USA
    Aliment Pharmacol Ther 19:197-208. 2004
  4. doi request reprint The economic value of primary prophylaxis using pegfilgrastim compared with filgrastim in patients with breast cancer in the UK
    Zhimei Liu
    Cerner LifeSciences, Beverly Hills, California, USA
    Appl Health Econ Health Policy 7:193-205. 2009
  5. ncbi request reprint Growth in use of lipid-lowering therapies: are we targeting the right patients?
    Robert W Dubois
    Zynx Health, Inc, Beverly Hills, California 90212, USA
    Am J Manag Care 8:862-7. 2002
  6. ncbi request reprint Evolution of clinical practice guidelines: evidence supporting expanded use of medicines
    Robert W Dubois
    Cerner LifeSciences, Beverly Hills, California 90212, USA
    Dis Manag 9:210-23. 2006
  7. doi request reprint Disease-specific cost savings of treating nighttime versus daytime gastroesophageal reflux disease in an employed population
    Quan V Doan
    Cerner LifeSciences, Beverly Hills, CA, USA
    J Med Econ 11:23-40. 2008
  8. ncbi request reprint Economic burden of cardiovascular events and fractures among patients with end-stage renal disease
    Quan V Doan
    Cerner LifeSciences, 9100 Wilshire Blvd, Suite 655E, Beverly Hills, CA 90212, USA
    Curr Med Res Opin 23:1561-9. 2007
  9. ncbi request reprint A systematic review evaluating health-related quality of life, work impairment, and health-care costs and utilization in abnormal uterine bleeding
    Zhimei Liu
    Cerner LifeSciences, 9100 Wilshire Boulevard, Beverly Hills, CA 90212, USA
    Value Health 10:183-94. 2007
  10. doi request reprint The relationship between the prevalence of nighttime gastroesophageal reflux disease and disease severity
    Bonnie B Dean
    Cerner LifeSciences, 9100 Wilshire Blvd, Suite 655 East Tower, Beverly Hills, CA, 90212, USA
    Dig Dis Sci 55:952-9. 2010

Detail Information

Publications24

  1. ncbi request reprint Identification, diagnosis, and management of anemia in adult ambulatory patients treated by primary care physicians: evidence-based and consensus recommendations
    Robert W Dubois
    Cerner Health Insights, Beverly Hills, CA 90212, USA
    Curr Med Res Opin 22:385-95. 2006
    ..Provide recommendations for the identification, diagnosis, and management of ambulatory patients with anemia...
  2. ncbi request reprint Geographic variation in the use of medications: is uniformity good news or bad?
    Robert W Dubois
    Zynx Health, Beverly Hills, California, USA
    Health Aff (Millwood) 21:240-50. 2002
    ..To determine whether these findings represent good or bad news will require further study...
  3. ncbi request reprint Guidelines for the appropriate use of non-steroidal anti-inflammatory drugs, cyclo-oxygenase-2-specific inhibitors and proton pump inhibitors in patients requiring chronic anti-inflammatory therapy
    R W Dubois
    Zynx Health Inc, Beverly Hills, CA 90212, USA
    Aliment Pharmacol Ther 19:197-208. 2004
    ..To rationalize decision making around the use of different non-steroidal anti-inflammatory drug (NSAID) treatment strategies in patients with varying degrees of gastrointestinal and cardiovascular risk...
  4. doi request reprint The economic value of primary prophylaxis using pegfilgrastim compared with filgrastim in patients with breast cancer in the UK
    Zhimei Liu
    Cerner LifeSciences, Beverly Hills, California, USA
    Appl Health Econ Health Policy 7:193-205. 2009
    ..Once-per-cycle pegfilgrastim and daily filgrastim are two commonly used G-CSFs with different dosing schedules and associated costs...
  5. ncbi request reprint Growth in use of lipid-lowering therapies: are we targeting the right patients?
    Robert W Dubois
    Zynx Health, Inc, Beverly Hills, California 90212, USA
    Am J Manag Care 8:862-7. 2002
    ..Concern exists that industry marketing has led to increased use of medications by patients with marginal indications...
  6. ncbi request reprint Evolution of clinical practice guidelines: evidence supporting expanded use of medicines
    Robert W Dubois
    Cerner LifeSciences, Beverly Hills, California 90212, USA
    Dis Manag 9:210-23. 2006
    ..These trends are likely to continue with important economic, clinical, and policy ramifications...
  7. doi request reprint Disease-specific cost savings of treating nighttime versus daytime gastroesophageal reflux disease in an employed population
    Quan V Doan
    Cerner LifeSciences, Beverly Hills, CA, USA
    J Med Econ 11:23-40. 2008
    ..This study aimed to evaluate the economic impact of treating GERD with PPIs versus no treatment, from an employer's perspective...
  8. ncbi request reprint Economic burden of cardiovascular events and fractures among patients with end-stage renal disease
    Quan V Doan
    Cerner LifeSciences, 9100 Wilshire Blvd, Suite 655E, Beverly Hills, CA 90212, USA
    Curr Med Res Opin 23:1561-9. 2007
    ..To quantify direct medical costs of fractures and cardiovascular diseases among end-stage renal disease (ESRD) patients...
  9. ncbi request reprint A systematic review evaluating health-related quality of life, work impairment, and health-care costs and utilization in abnormal uterine bleeding
    Zhimei Liu
    Cerner LifeSciences, 9100 Wilshire Boulevard, Beverly Hills, CA 90212, USA
    Value Health 10:183-94. 2007
    ..To date, this burden has not been systematically studied. We conducted a systematic review of the medical literature to evaluate the impact of AUB on HRQoL and to quantify the economic burden of AUB from a societal perspective...
  10. doi request reprint The relationship between the prevalence of nighttime gastroesophageal reflux disease and disease severity
    Bonnie B Dean
    Cerner LifeSciences, 9100 Wilshire Blvd, Suite 655 East Tower, Beverly Hills, CA, 90212, USA
    Dig Dis Sci 55:952-9. 2010
    ..Nighttime gastrointestinal reflux disease (GERD) prevalence and severity estimates vary substantially across studies...
  11. doi request reprint Does type of bolus insulin matter in the hospital? Retrospective cohort analysis of outcomes between patients receiving analogue versus human insulin
    Kelly J Ko
    Cerner LifeSciences, Beverly Hills, California, USA
    Clin Ther 32:1954-66. 2010
    ..Research suggests that analogue bolus insulin may be more effective in achieving blood glucose (BG) control compared with human bolus insulin...
  12. ncbi request reprint Review of eight pharmacoeconomic studies of the value of biologic DMARDs (adalimumab, etanercept, and infliximab) in the management of rheumatoid arthritis
    Quan V Doan
    Cerner LifeSciences, 9100 Wilshire Blvd, Suite 605E, Beverly Hills, CA 90212, USA
    J Manag Care Pharm 12:555-69. 2006
    ..Treatment options for the management of rheumatoid arthritis (RA) have expanded from the traditional disease-modifying antirheumatic drugs (DMARDs) to include the biologic DMARDs that inhibit tumor necrosis factoralpha (TNF-a)...
  13. ncbi request reprint Outpatient cancer drug costs: changes, drivers, and the future
    R J Halbert
    Protocare Sciences, Inc, Santa Monica, California 90404, USA
    Cancer 94:1142-50. 2002
    ..To the authors' knowledge, no analysis has examined the specific components of drug spending for overall cancer care. The authors' objective was to quantify and characterize trends in outpatient drug expenditures for cancer patients...
  14. doi request reprint Economic and clinical impact of inpatient diabetic hypoglycemia
    Suellen M Curkendall
    Cerner LifeSciences, Beverly Hills, California 90212, USA
    Endocr Pract 15:302-12. 2009
    ..To assess the clinical and economic impact of hypoglycemia that develops during hospitalization of patients with diabetes...
  15. ncbi request reprint Pharmaceutical promotion: don't throw the baby out with the bathwater
    Robert W Dubois
    Zynx Health Inc, Beverly Hills, California, USA
    Health Aff (Millwood) . 2003
    ....
  16. doi request reprint Development and validation of a case ascertainment tool for ankylosing spondylitis
    Michael H Weisman
    Cedars Sinai Medical Center, Los Angeles, California, USA
    Arthritis Care Res (Hoboken) 62:19-27. 2010
    ..We tested questions derived from a comprehensive literature review and an advisory board in a case-control study designed to identify patients with AS from among patients with chronic back pain (CBP)...
  17. ncbi request reprint Treatment of patients with metastatic renal cell cancer: a RAND Appropriateness Panel
    Ronald J Halbert
    Cerner Life Sciences, Beverley Hills, California, USA
    Cancer 107:2375-83. 2006
    ..The authors convened a panel of medical and urologic oncologists to rate the appropriateness of the main options...
  18. ncbi request reprint Septicemia in patients with ESRD is associated with decreased hematocrit and increased use of erythropoietin
    Allen R Nissenson
    David Geffen School of Medicine, University of California Los Angeles, 200 UCLA Medical Plaza, Suite 565 57, Los Angeles, CA 90095, USA
    Clin J Am Soc Nephrol 1:505-10. 2006
    ..Strategies to prevent septicemia are important not only to decrease clinical morbidity but also to conserve EPO usage and thus contain the costs of care for this complex patient population...
  19. ncbi request reprint Clinical and economic outcomes of Staphylococcus aureus septicemia in ESRD patients receiving hemodialysis
    Allen R Nissenson
    David Geffen School of Medicine, University of California, Los Angeles, CA, USA
    Am J Kidney Dis 46:301-8. 2005
    ..The purpose of this study is to identify clinical and economic consequences of hospitalizations for septicemia caused by Staphylococcus aureus in hemodialysis patients with ESRD...
  20. ncbi request reprint Economic burden of anemia in an insured population
    Allen R Nissenson
    Division of Nephrology, David Geffen School of Medicine, University of California, Los Angeles, 90095 6945, USA
    J Manag Care Pharm 11:565-74. 2005
    ..This study examines anemia prevalence and associated medical costs and utilization, using administrative claims for adults newly diagnosed with anemia, including up to 12 months of follow-up...
  21. ncbi request reprint Anemia: not just an innocent bystander?
    Allen R Nissenson
    Arch Intern Med 163:1400-4. 2003
  22. doi request reprint Impact of systemic hypertension on the cardiovascular benefits of statin therapy--a meta-analysis
    Franz H Messerli
    Division of Cardiology, St Luke s Roosevelt Hospital, New York, New York, USA
    Am J Cardiol 101:319-25. 2008
    ..51, p=0.22). In conclusion, statin therapy effectively decreases CV morbidity and mortality to the same extent in hypertensive and nonhypertensive patients...
  23. ncbi request reprint When is it appropriate to prescribe postmenopausal hormone therapy?
    Bruce Ettinger
    University of California, San Francisco, San Francisco, CA, USA
    Menopause 13:404-10. 2006
    ..To develop evidence and consensus-based recommendations for the use of hormone therapy (HT) in postmenopausal women...
  24. ncbi request reprint Cost-effectiveness of treatments for dysfunctional uterine bleeding in women who need contraception
    Paul D Blumenthal
    Department of Gynecology and Obstetrics, Johns Hopkins Bayview Medical Center, Johns Hopkins University School of Medicine, Baltimore, MD 21224, USA
    Contraception 74:249-58. 2006
    ....